Ryota Nakano

Dr. Ryota Nakano

Hyogo College of Medicine, Nishinomiya, Japan
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
RNRyota Nakano
Ryota Nakano
HSHideyuki Shiomi
Hideyuki Shiomi
AFAoi Fujiwara
Aoi Fujiwara
KYKohei Yoshihara
Kohei Yoshihara
RYRyota Yoshioka
Ryota Yoshioka
HIHiroko Iijima
Hiroko Iijima
The indications for immune checkpoint inhibitors (ICIs) have expanded to include carcinomas of various organs. However, as ICI therapy expands, the management of immune-related adverse events (irAEs) has become a problem. ICI-related pancreatitis and cholangitis are relatively rare irAEs. Although some patients with ICI-related pancreatitis and cholangitis are asymptomatic and do not require treatment, there have been reports of patients who did not respond to immunosuppressive therapy and died. Thus, the pathogenesis of ICI-related pancreatitis and cholangitis should be clarified immediately. Currently, the role of endoscopy in the diagnosis and treatment of inflammatory pancreatic and biliary duct diseases is becoming increasingly important. In this review, we summarize clinical characteristics as well as radiographic and endoscopic findings of ICI-related pancreatitis and cholangitis.

30 November 2021 in Clinical Endoscopy
Verified
Journal Article
Open access
PDF file
HSHideyuki Shiomi
Hideyuki Shiomi
ASArata Sakai
Arata Sakai
RNRyota Nakano
Ryota Nakano
SOShogo Ota
Shogo Ota
TKTakashi Kobayashi
Takashi Kobayashi
HIHiroko Iijima
Hiroko Iijima
Afferent loop syndrome (ALS) is a mechanical obstruction of the afferent limbs after gastrectomy with gastrojejunostomy reconstruction. Patients with cancer recurrence require immediate and less invasive treatment because of their poor condition. Percutaneous transhepatic/transluminal drainage (PTD) and endoscopic enteral stenting offer reasonable palliative treatment for malignant ALS but are not fully satisfactory in terms of patient quality of life (QoL) and stent patency. Endoscopic ultrasound-guided gastroenterostomy (EUS-GE) using a lumen-apposing metal stent may address these shortcomings. Clinical data from 11 reports showed that all patients who had undergone EUS-GE had positive technical and clinical outcomes. The adverse event rate was 11.4%, including only mild or moderate abdominal pain, with no severe adverse events. Indirect comparative studies indicated that patients who had undergone EUS-GE had a significantly superior QoL, a higher clinical success rate, and a lower reintervention rate than those who had undergone PTD or endoscopic enteral stenting. Although the evidence is limited, EUS-GE may be considered as a first-line treatment for malignant ALS because it has better clinical outcomes than other less invasive treatments, such as PTD or endoscopic enteral stenting. Further prospective randomized control trials are necessary to establish EUS-GE as a standard treatment for ALS.

30 July 2020 in Clinical Endoscopy
Verified
Journal Article
Open access
PDF file
ASArata Sakai
Arata Sakai
HSHideyuki Shiomi
Hideyuki Shiomi
TITakao Iemoto
Takao Iemoto
RNRyota Nakano
Ryota Nakano
TITakuya Ikegawa
Takuya Ikegawa
YKYuzo Kodama
Yuzo Kodama
In this study, we assessed a series of our cases in which endoscopic self-expandable metal stents (SEMSs) were used to treat malignant afferent loop obstruction (ALO) that arose after pancreaticoduodenectomy (PD). We retrospectively examined the records of 7 patients who underwent endoscopic SEMS placement for malignant ALO following PD. Clinical success was achieved in all cases. The median procedure time was 30 min (range, 15-50 min). There were no cases of stent occlusion, and no procedure-related adverse events were encountered. All patients died of their primary disease, and the median overall survival period was 155 days (range, 96-374 days). A re-intervention involving endoscopic ultrasound-guided hepaticogastrostomy combined with antegrade stenting was performed for obstructive jaundice and acute cholangitis in 1 case. In conclusion, endoscopic SEMS placement may be an effective and safe treatment for malignant ALO that arises after PD.

9 November 2022 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
NINoriko Inomata
Noriko Inomata
AMAtsuhiro Masuda
Atsuhiro Masuda
KYKohei Yamakawa
Kohei Yamakawa
MTMamoru Takenaka
Mamoru Takenaka
MTMasahiro Tsujimae
Masahiro Tsujimae
YKYuzo Kodama
Yuzo Kodama

22 January 2024 in Pancreatology
Verified
Journal Article
Closed access
MTMasahiro Tsujimae
Masahiro Tsujimae
AMAtsuhiro Masuda
Atsuhiro Masuda
MTMegumi Takagi
Megumi Takagi
TKTakao Kato
Takao Kato
RNRyota Nakano
Ryota Nakano
YKYuzo Kodama
Yuzo Kodama

16 January 2022 in Life
Verified
Journal Article
Open access
PDF file
NINoriko Ishii-Kitano
Noriko Ishii-Kitano
HEHirayuki Enomoto
Hirayuki Enomoto
TNTakashi Nishimura
Takashi Nishimura
NANobuhiro Aizawa
Nobuhiro Aizawa
YSYoko Shibata
Yoko Shibata
HIHiroko Iijima
Hiroko Iijima
Inflammatory pseudotumor (IPT) of the liver is a rare benign disease. IPTs generally develop as solitary nodules, and cases with multiple lesions are uncommon. We herein report a case of multiple IPTs of the liver that spontaneously regressed. A 70-year-old woman with a 10-year history of primary biliary cholangitis and rheumatoid arthritis visited our hospital to receive a periodic medical examination. Abdominal ultrasonography revealed multiple hypoechoic lesions, with a maximum size of 33 mm, in the liver. Contrast-enhanced computed tomography revealed low-attenuation areas in the liver with mild peripheral enhancement at the arterial and portal phases. We first suspected metastatic liver tumors, but fluorodeoxyglucose positron emission tomography, magnetic resonance imaging and contrast-enhanced ultrasonography suggested the tumors to be inconsistent with malignant nodules. A percutaneous biopsy showed shedding of liver cells and abundant fibrosis with infiltration of inflammatory cells. Given these findings, we diagnosed the multiple tumors as IPTs. After careful observation for two months, the tumors almost vanished spontaneously. Physicians should avoid a hasty diagnosis of multiple tumors based solely on a few clinical findings, and a careful assessment with various imaging modalities should be conducted.